CND SolarOil Nail and Cuticle Conditioner

Product Information

Iffland K, Grotenhermen F. An update on safety and side effects of cannabidiol: a review of clinical data and relevant animal studies. Cannabis Cannabinoid Res. 2017;2(1):139-154. doi:10.1089/can.2016.0034 There’s also some limited evidence that CBD may also be effective in improving the symptoms of other neurological conditions, such as: Full-spectrum CBD does contain THC, the compound associated with feeling high. But by federal law, it must be in very small amounts (less than 0.3%). Antidepressants like Paxil (paroxetine), Celexa (citalopram), Remeron (mirtazapine), and Tofranil (imipramine). CBD may increase the levels of these medicines and exacerbate their side effects.

Boyaji S, Merkow J, Elman RNM, Kaye AD, Yong RJ, Urman RD. The Role of Cannabidiol (CBD) in Chronic Pain Management: An Assessment of Current Evidence. Current Pain and Headache Reports. 2020;24(2). doi:10.1007/s11916-020-0835-4 Food and Drug Administration. Guidance for Industry, Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients. Initial CBD studies [ Neurotherapeutics . 2015] found that CBD helps inhibit ‘drug-seeking behavior with viritually no possibility of abuse or over-use. Therapeutic effects of CBD have taken 4-6 weeks of constant use to start seeing any clinical effects.

Frequently Asked Questions (FAQs)

Ryan SA, Ammerman SD, O'Connor ME. Marijuana use during pregnancy and breastfeeding: implications for neonatal and childhood outcomes. Pediatrics. 2018;142(3) doi:10.1542/peds.2018-1889

Medical News Today has strict sourcing guidelines and draws only from peer-reviewed studies, academic research institutions, and medical journals and associations. We avoid using tertiary references. We link primary sources — including studies, scientific references, and statistics — within each article and also list them in the resources section at the bottom of our articles. You can learn more about how we ensure our content is accurate and current by reading our editorial policy. The study found that CBD reduced vascular tension by 40% as a maximum of pre-existing condition. This includes human arteries, involving CB1 receptor activation. CBD has been found through clinical studies to help Multiple Sclerosis (MS). A product called Sativex, which consists of an equal ratio of Tetrahydrocannabinol (THC) and CBD was approved in Canada 2005 as a treatment for neuropathic pain in MS, as CBD binds to those receptors with endocannabinoid modulating effects. Rajesh M, Mukhopadhyay P, Bátkai S, et al. Cannabidiol attenuates high glucose-induced endothelial cell inflammatory response and barrier disruption. American Journal of Physiology-Heart and Circulatory Physiology. 2007;293(1):H610-H619.

After 4 weeks, the researchers noted a statistically significant reduction in intense pain, sharp pain, cold and itchy sensations in those using CBD oil. Participants did not report any side effects.